Početna › Ulcerativni kolitis › Florida › Orlando

Kliničke studije za Ulcerativni kolitis u gradu Orlando, FL

22 studija za Ulcerativni kolitis traži sudionike na lokacijama u gradu Orlando i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

U tijeku regrutacijaFaza 2

Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
Clinical Research of Osceola /ID# 280593, Kissimmee · 16 mi udaljenosti

Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

U tijeku regrutacijaFaza 4

Endoscopic Research, Inc., Orlando
Orlando Health-Orlando Regional Medical Center, Orlando
Digestive and Liver Center of Florida, P.A., Kissimmee · 16 mi udaljenosti

Od 18 do 80 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06581328

Confirmatory Clinical Study in Active Ulcerative Colitis

U tijeku regrutacijaFaza 2

Orlando Gastroenterology, P.A., Orlando

Od 16 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07296315

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

U tijeku regrutacijaFaza 2

Orlando Health Digestive Health Institute, Orlando
AdventHealth Orlando, Orlando
Novum Research, LLC, Clermont · 24 mi udaljenosti

Od 18 do 75 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli

Xencor Investigative Site, Kissimmee · 16 mi udaljenosti

Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

U tijeku regrutacijaFaza 2

Site 007, Kissimmee · 16 mi udaljenosti

Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

U tijeku regrutacijaFaza 2

Site US-026, Orlando

Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

U tijeku regrutacijaFaza 2

AdventHealth Orlando ( Site 1074), Orlando

Od 18 do 75 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT07463183

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

U tijeku regrutacijaFaza 2

Clinical Research of Osceola, LLC, Kissimmee · 16 mi udaljenosti

Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06979336

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

U tijeku regrutacijaFaza 3

Orlando Health, Orlando
Digestive and Liver Center of Florida, Orlando

Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

U tijeku regrutacijaFaza 2

Digestive and Liver Center of Florida, Orlando
Clinical Research of Osceola, Kissimmee · 16 mi udaljenosti

Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

U tijeku regrutacijaFaza 2

AdventHealth Orlando, Orlando
Clinical Research of Osceola, Kissimmee · 16 mi udaljenosti

Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

U tijeku regrutacijaFaza 4

Endoscopic Research Inc, Orlando

Od 18 do 65 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

U tijeku regrutacijaFaza 3

Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 16 mi udaljenosti

Od 16 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07185009

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

U tijeku regrutacijaFaza 2

Primary Care of Osceola, Kissimmee · 16 mi udaljenosti

Od 18 do 80 godina · Oba spola · Ažurirano 21. kol 2026. · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

U tijeku regrutacijaFaza 3

Orlando Health, Inc. - Site Number: 8400084, Orlando
AdventHealth Orlando - Site Number: 8400070, Orlando
Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 16 mi udaljenosti
i još 1

Od 16 do 80 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07184996